Preeclampsia Among African American Pregnant Women: An Update on Prevalence, Complications, Etiology, and Biomarkers

Abstract

Importance Preeclampsia is a devastating disease of pregnancy associated with increased risk of fetal and maternal complications. African American pregnant women have a high prevalence of preeclampsia, but there is a need of systemic analyses of this high-risk group regarding complications, etiology, and biomarkers. Objective The aim of this study was to provide a synopsis of current research of preeclampsia specifically related to African American women. Evidence Acquisition A comprehensive search was performed in the bibliographic database PubMed with keywords “preeclampsia” and “African American.” Results African American women with preeclampsia were at an increased risk of preterm birth, which resulted in low-birth-weight infants. Intrauterine fetal death among African American preeclamptic patients occurs at twice the rate as in other races. On the maternal side, African American mothers with preeclampsia have more severe hypertension, antepartum hemorrhage, and increased mortality. Those who survive preeclampsia have a high risk of postpartum cardiometabolic disease. Preexisting conditions (eg, systemic lupus erythematosus) and genetic mutations (eg, sickle cell disease in the mother, FVL or APOL1 mutations in the fetus) may contribute to the higher prevalence and worse outcomes in African American women. Many blood factors, for example, the ratio of proteins sFlt/PlGF, hormones, and inflammatory factors, have been studied as potential biomarkers for preeclampsia, but their specificity needs further investigation. Conclusions Further studies of preeclampsia among African American women addressing underlying risk factors and etiologies, coupled with identification of preeclampsia-specific biomarkers allowing early detection and intervention, will significantly improve the clinical management of this devastating disease. Target Audience Obstetricians and gynecologists, family physicians. Learning Objectives After completing this activity, the learner should be better able to describe the difference in prevalence of fetal and maternal complications among African American women with preeclampsia versus women of other races; explain updated genetic studies of preeclampsia specifically related to African American women; and analyze current research of biomarkers for prediction of status and progress of preeclampsia.

Doula care across the maternity care continuum and impact on maternal health: Evaluation of doula programs across three states using propensity score matching

“…Similarly, women with pregnancy complications who received doula care showed a 54% reduction in odds of PPA/PPD diagnosis, relative to similar women without doula care. Because Black women have a higher prevalence of some of the most common conditions women can acquire during pregnancy, including pre-eclampsia, 25 anemia, 26 and symptoms of depression or anxiety, 27 doula care targeted toward Black women may help bridge the gap in health outcomes between White and Black women enrolled in Medicaid. Our study findings suggest that doulas help mitigate the effects of high risk pregnancy characteristics on maternal health outcomes.…”

Effect of Educational Program of Eclampsia Management on Knowledge of Maternity Nurses at Mosul Teaching Hospitals

“…Eclampsia affects about (5-8%) of all pregnancies, the recent report of the World Health Organization (WHO) shows that statistics suggest 76,000 maternal mortality and morbidity annually worldwide and about 500,000 child deaths due to Preeclampsia [4] [5].…”

RAR-Related Orphan Receptor: An Accelerated Preeclampsia Progression by Activating the JAK/STAT3 Pathway

“…Therefore, the discovery of new diagnostic markers and therapeutic targets is beneficial to the treatment of PE. 16 A previous study showed that in human melanomas, RORA, as a target of hypoxia-inducible factor 1 alpha, was up-regulated in hypoxia. 17 Furthermore, Qiu, et al 18 19 reported that the SNPs of RORA in the placental genome were associated with placental abruption risk.…”